|
Randomized Controlled Trial
Citations 1-10 of 115 total displayed.
|
Most recent content
(1 Sep 2009):
|
- Clinical Trials
A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 5
- The SCORE Study Research Group
Arch Ophthalmol 2009; 127: 1101-1114.
[Abstract]
[Full text]
[PDF]
[ eTable ]
- Clinical Trials
A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Standard Care to Treat Vision Loss Associated With Macular Edema Secondary to Branch Retinal Vein Occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 6
- The SCORE Study Research Group
Arch Ophthalmol 2009; 127: 1115-1128.
[Abstract]
[Full text]
[PDF]
|
Past content
(since May 1999):
|
- Research Letters
Infliximab Therapy for Refractory Uveitis: 2-Year Results of a Prospective Trial
- Eric B. Suhler; Justine R. Smith; Tracy R. Giles; Andreas K. Lauer; Michael S. Wertheim; Daryl E. Kurz; Paul A. Kurz; Lyndell Lim; Friederike Mackensen; Terri D. Pickard; James T. Rosenbaum
Arch Ophthalmol 2009; 127: 819-822.
[Extract]
[Full text]
[PDF]
- Clinical Trials
Retinal Effects of 6 Months of Daily Use of Tadalafil or Sildenafil
- William H. Cordell; Raj K. Maturi; Timothy M. Costigan; Michael F. Marmor; Richard G. Weleber; Stuart G. Coupland; Ronald P. Danis; John W. McGettigan Jr; Andrew N. Antoszyk; Suzanne Klise; Gregory D. Sides; for the ERG Testing During Chronic PDE5 Inhibitor Administration (ERG-PDE5i) Consortium
Arch Ophthalmol 2009; 127: 367-373.
[Abstract]
[Full text]
[PDF]
[ eFigure and eTables ]
- Clinical Trials
Pegaptanib Sodium for Macular Edema Secondary to Central Retinal Vein Occlusion
- John J. Wroblewski; John A. Wells III; Anthony P. Adamis; Ronald R. Buggage; Emmett T. Cunningham Jr; Mauro Goldbaum; David R. Guyer; Barrett Katz; Michael M. Altaweel; for the Pegaptanib in Central Retinal Vein Occlusion Study Group
Arch Ophthalmol 2009; 127: 374-380.
[Abstract]
[Full text]
[PDF]
- Clinical Trials
Topical Bevacizumab in the Treatment of Corneal Neovascularization: Results of a Prospective, Open-Label, Noncomparative Study
- Mohammad H. Dastjerdi; Khalid M. Al-Arfaj; Nambi Nallasamy; Pedram Hamrah; Ula V. Jurkunas; Roberto Pineda II; Deborah Pavan-Langston; Reza Dana
Arch Ophthalmol 2009; 127: 381-389.
[Abstract]
[Full text]
[PDF]
- Clinical Sciences
Three-Year Follow-up of a Randomized Trial Comparing Focal/Grid Photocoagulation and Intravitreal Triamcinolone for Diabetic Macular Edema
- Diabetic Retinopathy Clinical Research Network (DRCR.net)
Arch Ophthalmol 2009; 127: 245-251.
[Abstract]
[Full text]
[PDF]
- Clinical Trials
Improved Vision-Related Function After Ranibizumab vs Photodynamic Therapy: A Randomized Clinical Trial
- Neil M. Bressler; Tom S. Chang; Jennifer T. Fine; Chantal M. Dolan; James Ward; for the Anti-VEGF Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization in Age-Related Macular Degeneration (ANCHOR) Research Group
Arch Ophthalmol 2009; 127: 13-21.
[Abstract]
[Full text]
[PDF]
[ eFigures and eTables ]
- Clinical Trials
Pharmacological Plus Optical Penalization Treatment for Amblyopia: Results of a Randomized Trial
- Pediatric Eye Disease Investigator Group
Arch Ophthalmol 2009; 127: 22-30.
[Abstract]
[Full text]
[PDF]
[ eTables ]
- Clinical Trials
Surgical Removal vs Observation for Idiopathic or Ocular Histoplasmosis Syndrome–Associated Subfoveal Choroidal Neovascularization: Vision Preference Value Scale Findings From the Randomized SST Group H Trial: SST Report No. 17
- Submacular Surgery Trials Research Group
Arch Ophthalmol 2008; 126: 1626-1632.
[Abstract]
[Full text]
[PDF]
[ eTable and eFigures ]
|
|
